title: Failure patterns of cryopreserved vein grafts in liver transplantation.
abstract: Reports of early success with cryopreserved saphenous veins (CSV) as arterial conduits led us to develop cryopreserved iliac veins (CIV) as interposition grafts for portal vein reconstruction in living-related liver transplantation (LRLT). Despite encouraging short-term results, retrospective analysis of long-term cryopreserved vein graft performance in LRLT at our institution has revealed a high rate of late graft failures. Between July 1992 and JUly 1994, interposition grafts (CIV for portal vein interposition n=4, CSV for portal vein interposition n=3, and CSV for hepatic artery interposition n=2) were utilized in 7 LRLT. (Two transplanted organs had both CIV and CSV grafts.) Recipients included 5 children and two small adults (median: 3.5 years, range: 0.5--59 years). Posttransplant follow-up in excess of 36 months revealed portal vein (PV) and hepatic artery (HA) complications of cryopreserved grafts in each patient. PV complications included aneurysm (n=4) diagnosed at 28, 24, 18, and 1.5 mo, stricture (n=1) diagnosed at 11 mo, and thrombosis (n=1) diagnosed at 18 mo posttransplantation. All portal vein complications have been managed without retransplantation, but one (PV thrombosis) necessitated surgical shunt therapy. Each CSV hepatic artery interposition graft has been complicated by thrombosis (diagnosed at 11 days and 24 mo posttransplant) necessitating retransplantation. Based on these observations, we have adopted alternative strategies for HA and PV reconstruction. At present, 11 LRLT have been performed without cryopreserved vein conduits over 17 mo with no vascular complications. While this study does not permit statistical analysis, these results discourage the use cryopreserved iliac veins for portal interposition and cryopreserved saphenous veins for arterial interposition in liver transplantation.
authors.affiliation: Department of Surgery, University of California, San Francisco 94143, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: Kuang
authors.forename: J F
authors.initials: JF
authors.lastname: Renz
authors.forename: L D
authors.initials: LD
authors.lastname: Ferrell
authors.forename: E J
authors.initials: EJ
authors.lastname: Ring
authors.forename: P
authors.initials: P
authors.lastname: Rosenthal
authors.forename: R C
authors.initials: RC
authors.lastname: Lim
authors.forename: J P
authors.initials: JP
authors.lastname: Roberts
authors.forename: N L
authors.initials: NL
authors.lastname: Ascher
authors.forename: J C
authors.initials: JC
authors.lastname: Emond
mesh_terms: D000293:Adolescent; D000328:Adult; D000783:Aneurysm / Q000209:etiology* / Q000517:prevention & control; D001807:Blood Vessel Prosthesis; D002648:Child; D015925:Cryopreservation; D005260:Female; D006083:Graft Occlusion, Vascular / Q000209:etiology* / Q000517:prevention & control; D006499:Hepatic Artery / Q000601:surgery*; D006801:Humans; D007084:Iliac Vein; D008099:Liver / Q000098:blood supply*; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D009926:Organ Preservation / Q000379:methods*; D011169:Portal Vein / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control; D012189:Retrospective Studies; D012501:Saphenous Vein; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D017211:Treatment Failure